A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Severe Steroid Dependent Asthma
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Dupilumab (Primary) ; Prednisolone; Prednisolone; Prednisone; Prednisone
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Acronyms VENTURE
- Sponsors Sanofi
- 05 Jul 2017 This trial has been completed in spain according to European Clinical Trials Database record.
- 15 May 2017 Planned primary completion date changed from 1 Dec 2017 to 20 Sep 2017.
- 24 Apr 2017 Status changed from recruiting to active, no longer recruiting.